Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Fear of new foods may affect more than dietary variety

14

Jul 2026

Fear of new foods may affect more than dietary variety

Higher food neophobia was associated with poorer self-reported physical and mental health among 4,537 adults in Australia, the United Kingdom, and the United States. The relationship remained after accounting for age, gender, education, and country, although the cross-sectional study could not establish causation.

Humanoid robots could take on low-risk operating room tasks before assisting surgical teams

14

Jul 2026

Humanoid robots could take on low-risk operating room tasks before assisting surgical teams

A new perspective proposes a staged framework for introducing humanoid robots into operating rooms, beginning with laboratory testing and low-risk perioperative tasks. The authors argue that humanoids could support supplies, equipment, room turnover, and selected nursing functions, but autonomous clinical use remains premature and requires rigorous validation, governance, and human oversight.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.